CA1338596C
(en)
*
|
1988-09-27 |
1996-09-17 |
Hiroyoshi Koyama |
Granules having core and their production
|
NZ233403A
(en)
*
|
1989-04-28 |
1992-09-25 |
Mcneil Ppc Inc |
Simulated capsule-like medicament
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5540945A
(en)
*
|
1989-05-11 |
1996-07-30 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
|
US5084287A
(en)
*
|
1990-03-15 |
1992-01-28 |
Warner-Lambert Company |
Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
|
JP2542122B2
(ja)
*
|
1990-04-18 |
1996-10-09 |
旭化成工業株式会社 |
球状核、球形顆粒およびその製造方法
|
DE69111287T2
(de)
*
|
1990-04-18 |
1995-12-21 |
Asahi Chemical Ind |
Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
|
TW212139B
(de)
*
|
1991-04-15 |
1993-09-01 |
Yamanouchi Pharma Co Ltd |
|
TW209174B
(de)
*
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
EP0520119A1
(de)
*
|
1991-06-17 |
1992-12-30 |
Spirig Ag Pharmazeutische Präparate |
Neue orale Diclofenaczubereitung
|
AU664561B2
(en)
*
|
1991-06-21 |
1995-11-23 |
University Of Cincinnati, The |
Orally administrable therapeutic proteins and method of making
|
US6613332B1
(en)
|
1991-06-21 |
2003-09-02 |
The University Of Cincinnati |
Oral administration of therapeutic proteins
|
US5356629A
(en)
*
|
1991-07-12 |
1994-10-18 |
United States Surgical Corporation |
Composition for effecting bone repair
|
US5213811A
(en)
*
|
1991-09-13 |
1993-05-25 |
Sterling Drug Inc. |
Oral sustained-release drug compositions
|
US5225202A
(en)
*
|
1991-09-30 |
1993-07-06 |
E. R. Squibb & Sons, Inc. |
Enteric coated pharmaceutical compositions
|
FR2682874B1
(fr)
*
|
1991-10-24 |
1993-12-10 |
Rinrone Ets |
Procede pour la preparation d'un extrait de principes actifs sous forme seche adsorbable et microgranules adsorbables ainsi obtenus.
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
IT1252185B
(it)
*
|
1991-12-11 |
1995-06-05 |
Therapicon Srl |
Preparazioni farmaceutiche a liberazione programmata
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
JP2964195B2
(ja)
*
|
1992-04-28 |
1999-10-18 |
エスエス製薬株式会社 |
ピロキシカム錠及びその製造法
|
DK0661045T3
(da)
*
|
1992-09-18 |
2002-10-28 |
Yamanouchi Pharma Co Ltd |
Hydrogelpræparat med forsinket frigivelse
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
DE69332801T2
(de)
*
|
1992-11-30 |
2004-01-29 |
Kv Pharm Co |
Geschmacksmaskierte pharmazeutische substanzen
|
EP0603992B2
(de)
*
|
1992-12-22 |
2000-12-06 |
University Of Cincinnati |
Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen
|
ES2133158T3
(es)
*
|
1993-01-19 |
1999-09-01 |
Warner Lambert Co |
Formulacion ci-981 oral, estable y proceso de preparacion del mismo.
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
SE9301489D0
(sv)
*
|
1993-04-30 |
1993-04-30 |
Ab Astra |
Veterinary composition
|
IL119660A
(en)
*
|
1993-05-10 |
2002-09-12 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
FR2711525B1
(fr)
*
|
1993-10-29 |
1996-01-12 |
Virbac Laboratoires |
Forme Galénique à administration orale pour animaux, son procédé de préparation et ses applications.
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5458887A
(en)
*
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
US7060293B1
(en)
|
1994-05-25 |
2006-06-13 |
Purdue Pharma |
Powder-layered oral dosage forms
|
US6077533A
(en)
*
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
US5411745A
(en)
*
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
SE9402422D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New beads for controlled release and a pharmaceutical preparation containing the same
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
US7008668B2
(en)
|
1995-05-09 |
2006-03-07 |
Phoqus Pharmaceuticals Limited |
Powder coating composition for electrostatic coating of pharmaceutical substrates
|
CN1183715A
(zh)
|
1995-05-09 |
1998-06-03 |
科洛康有限公司 |
适合药物基质静电包衣的粉末包衣物质
|
BE1009856A5
(fr)
*
|
1995-07-14 |
1997-10-07 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
|
SE9600046D0
(sv)
*
|
1996-01-05 |
1996-01-05 |
Astra Ab |
New pharmaceutical formulation
|
JP4090529B2
(ja)
*
|
1996-01-24 |
2008-05-28 |
フロイント産業株式会社 |
乳糖の球形粒及びその製造方法
|
DE19714024A1
(de)
*
|
1996-04-04 |
1997-11-20 |
L A B Ges Fuer Pharmakologisch |
Verfahren zur Herstellung von gering dosierten freifließenden und/oder direktkomprimierbaren Pulversystemen
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
DE19630035A1
(de)
*
|
1996-07-25 |
1998-01-29 |
Asta Medica Ag |
Tramadol Multiple Unit Formulierungen
|
FR2752732B1
(fr)
*
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
JPH10139659A
(ja)
*
|
1996-09-10 |
1998-05-26 |
Freunt Ind Co Ltd |
球形粒子群、その製造方法及びそれを用いた球形粒子製剤
|
GB9623634D0
(en)
*
|
1996-11-13 |
1997-01-08 |
Bpsi Holdings Inc |
Method and apparatus for the coating of substrates for pharmaceutical use
|
US5989591A
(en)
*
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
SI9700186B
(sl)
*
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
ATE241341T1
(de)
|
1997-09-10 |
2003-06-15 |
Takeda Chemical Industries Ltd |
Stabilisierte pharmazeutische zusammensetzung
|
DE19754324A1
(de)
*
|
1997-12-08 |
1999-06-10 |
Byk Gulden Lomberg Chem Fab |
Neue Darreichungsform enthaltend einen säurelabilen Wirkstoff
|
AU751066B2
(en)
|
1997-12-08 |
2002-08-08 |
Nycomed Gmbh |
Novel administration form comprising an acid-labile active compound
|
FR2774910B1
(fr)
*
|
1998-02-16 |
2001-09-07 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
JP3718341B2
(ja)
*
|
1998-05-12 |
2005-11-24 |
信越化学工業株式会社 |
低置換度ヒドロキシプロピルセルロースとその製造方法
|
KR100554924B1
(ko)
*
|
1998-05-18 |
2006-03-03 |
다케다 야쿠힌 고교 가부시키가이샤 |
구강내 붕괴 정제
|
UA69413C2
(uk)
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
US7122207B2
(en)
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
UA73092C2
(uk)
*
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
DE69924381T2
(de)
*
|
1998-07-28 |
2006-04-20 |
Takeda Pharmaceutical Co. Ltd. |
Leicht zerfallende feste zubereitung
|
GT199900148A
(es)
*
|
1998-09-10 |
2001-02-28 |
|
Desnaturalizantes para las sales aminas simpaticomimeticas.
|
KR100314351B1
(ko)
*
|
1998-10-01 |
2002-03-21 |
민경윤 |
벤즈이미다졸유도체의장용성제제및그제조방법
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
FR2790668B1
(fr)
*
|
1999-03-12 |
2002-07-26 |
D B F |
Granules contenant une substance vegetale et leur procede de preparation
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
EP1180022A4
(de)
*
|
1999-05-14 |
2004-01-07 |
Lilly Co Eli |
Prozess zur massenherstellung von pharmazeutischem material mit einheitlicher löslichkeit
|
IL146504A0
(en)
|
1999-06-07 |
2002-07-25 |
Byk Gulden Lomberg Chem Fab |
Pharmaceutical compositions containing an acid-labile active compound and processes for the preparation thereof
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
FR2796840B1
(fr)
*
|
1999-07-26 |
2003-06-20 |
Ethypharm Lab Prod Ethiques |
Comprimes faiblement doses et procede de preparation
|
ES2168043B1
(es)
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
US6228400B1
(en)
|
1999-09-28 |
2001-05-08 |
Carlsbad Technology, Inc. |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
|
CN1171639C
(zh)
*
|
1999-10-12 |
2004-10-20 |
第一三得利制药株式会社 |
口服药物组合物
|
US20040202714A1
(en)
*
|
1999-10-12 |
2004-10-14 |
Daiichi Suntory Pharma Co., Ltd. |
Oral pharmaceutical composition
|
US6503761B1
(en)
|
1999-10-19 |
2003-01-07 |
Kimberly-Clark Worldwide, Inc. |
Selective removal of contaminants from a surface using articles having magnets
|
US6841393B2
(en)
|
1999-10-19 |
2005-01-11 |
Kimberly-Clark Worldwide, Inc. |
Selective removal of contaminants from a surface using colored particles and articles having magnets
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
PT1623703E
(pt)
|
1999-10-29 |
2012-01-09 |
Euro Celtique Sa |
Formulações de hidrocodona de libertação controlada
|
US6680069B1
(en)
|
1999-11-09 |
2004-01-20 |
Shin-Etsu Chemical Co., Ltd. |
Low-substituted hydroxypropyl cellulose and process for manufacturing the same
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
EP1108431B1
(de)
*
|
1999-12-16 |
2003-05-02 |
Laboratorio Medinfar-Produtos Farmaceuticos, S.A. |
Piroxicam enthaltende gastrointestinale Zubereitung aus merheren Einheiten bestehend
|
DE69925740T2
(de)
*
|
1999-12-16 |
2006-05-11 |
Laboratorio Medinfar-Produtos Farmacéuticos, S. A. |
Neue stabile mehreinheitliche substituierte Benzimidazole enthaltende pharmazeutische Präparate
|
JP3552160B2
(ja)
|
2000-01-14 |
2004-08-11 |
信越化学工業株式会社 |
低置換度ヒドロキシプロピルセルロース粒子の形成方法
|
GB0002305D0
(en)
|
2000-02-01 |
2000-03-22 |
Phoqus Limited |
Power material for electrostatic application
|
JP4795542B2
(ja)
|
2000-04-10 |
2011-10-19 |
株式会社クレハ |
近赤外光吸収性組成物及び光学材料
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US20020035107A1
(en)
|
2000-06-20 |
2002-03-21 |
Stefan Henke |
Highly concentrated stable meloxicam solutions
|
MY130475A
(en)
|
2000-08-25 |
2007-06-29 |
Contura As |
Polyacrylamide hydrogel and its use as an endoprosthesis
|
DK1642885T3
(da)
|
2000-08-29 |
2010-01-04 |
Biocon Ltd |
Anvendelse af et farmaceutisk præparat der indeholder et para-aminophenyl-eddikesyrederivat til behandling af inflammatoriske tilstande i mave-tarmkanalen
|
AU2001288102A1
(en)
*
|
2000-09-22 |
2002-04-02 |
Takeda Chemical Industries Ltd. |
Solid preparations
|
JP3595765B2
(ja)
*
|
2000-09-27 |
2004-12-02 |
信越化学工業株式会社 |
低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
EP2283829A1
(de)
|
2000-10-30 |
2011-02-16 |
Euro-Celtique S.A. |
Hydrocodon-Formulierungen mit gesteuerter Freisetzung
|
FR2816507B1
(fr)
*
|
2000-11-16 |
2003-02-28 |
Ethypharm Lab Prod Ethiques |
Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
EP1364650A1
(de)
*
|
2001-01-30 |
2003-11-26 |
Teijin Limited |
Medizinische zusammensetzung
|
US20030022203A1
(en)
*
|
2001-04-23 |
2003-01-30 |
Rajan Kumar |
Cellular Arrays
|
US20110104214A1
(en)
*
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
JP4848101B2
(ja)
*
|
2001-08-17 |
2011-12-28 |
株式会社フジモト・コーポレーション |
徐放性マイクロペレット
|
US8048924B2
(en)
*
|
2001-08-29 |
2011-11-01 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
US8309118B2
(en)
*
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
DK1459737T3
(da)
|
2001-10-17 |
2013-01-02 |
Takeda Pharmaceutical |
Granulat indeholdende syreustabilt kemisk middel i stor mængde
|
US20030077378A1
(en)
*
|
2001-10-22 |
2003-04-24 |
Lou Wen Chin |
Hydroxypropyl cellulose encapsulation material
|
CA2481091A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Penwest Pharmaceuticals Co. |
Sustained release metoprolol formulations
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
BR0309093A
(pt)
|
2002-04-09 |
2005-02-09 |
Flamel Tech Sa |
Formulação farmacêutica oral sob a forma de suspensão aquosa de microcápsulas permitindo a liberação modificada de amoxicilina
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
KR100873419B1
(ko)
*
|
2002-06-18 |
2008-12-11 |
페어차일드코리아반도체 주식회사 |
높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
US20040029959A1
(en)
*
|
2002-08-08 |
2004-02-12 |
John Devane |
Isosorbide mononitrate compositions and methods of their use
|
EP1396263A1
(de)
*
|
2002-08-09 |
2004-03-10 |
Warner-Lambert Company |
Filmüberzüge für Tabletten oder Caplets
|
US20040028737A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
WO2004018454A1
(en)
*
|
2002-08-21 |
2004-03-04 |
Teva Pharmaceutical Industries Ltd. |
A method for the purification of lansoprazole
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
ES2534713T3
(es)
|
2002-10-16 |
2015-04-27 |
Takeda Pharmaceutical Company Limited |
Preparaciones sólidas estables
|
US8992980B2
(en)
*
|
2002-10-25 |
2015-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Water-soluble meloxicam granules
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
CA2517005A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
CA2518780C
(en)
|
2003-03-12 |
2014-05-13 |
Takeda Pharmaceutical Company Limited |
Drug composition having active ingredient adhered at high concentration to spherical core
|
ES2234393B2
(es)
*
|
2003-04-29 |
2006-09-01 |
Laboratorios Belmac, S.A. |
"formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
ITMI20031096A1
(it)
*
|
2003-05-30 |
2004-11-30 |
Eurand Spa |
Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
|
US7314640B2
(en)
*
|
2003-07-11 |
2008-01-01 |
Mongkol Sriwongjanya |
Formulation and process for drug loaded cores
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP2006528181A
(ja)
*
|
2003-07-18 |
2006-12-14 |
サンタラス インコーポレイティッド |
酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
|
CA2531566C
(en)
*
|
2003-07-18 |
2013-05-07 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
CN1893956A
(zh)
*
|
2003-07-25 |
2007-01-10 |
沃纳奇尔科特公司 |
多西环素金属络合物固体剂型
|
MXPA06003450A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
|
KR101148734B1
(ko)
*
|
2003-10-10 |
2012-07-05 |
에띠빠흠 |
징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
US20050142203A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Grant Heinicke |
Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same
|
CA2554271A1
(en)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
EP1568369A1
(de)
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
|
WO2005092297A2
(en)
*
|
2004-03-03 |
2005-10-06 |
Teva Pharmaceutical Industries Ltd. |
A stable pharmaceutical composition comprising an acid labile drug
|
US7612071B2
(en)
*
|
2004-03-12 |
2009-11-03 |
Syntrix Biosystems, Inc. |
Compositions and methods employing aminopterin
|
GB0407312D0
(en)
|
2004-03-31 |
2004-05-05 |
Phoqus Pharmaceuticals Ltd |
Method and apparatus for the application of powder material to substrates
|
JP2007532677A
(ja)
*
|
2004-04-16 |
2007-11-15 |
サンタラス インコーポレイティッド |
プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
*
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AU2005264864B2
(en)
|
2004-06-16 |
2011-08-11 |
Takeda Pharmaceutical Company Limited |
Multiple PPI dosage form
|
WO2006014549A2
(en)
|
2004-07-07 |
2006-02-09 |
Nobex Corporation |
Synthesis of azo bonded immunoregulatory compounds
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US20060062811A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Szymczak Christopher E |
Medicinal cooling emulsions
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
EP1802285B1
(de)
|
2004-10-21 |
2013-02-27 |
Aptalis Pharmatech, Inc. |
Geschmacksverdeckende pharmazeutische zusammensetzungen mit magenlöslichen porenbildnern
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
WO2006054175A2
(en)
*
|
2004-11-18 |
2006-05-26 |
Aurobindo Pharma Limited |
Stable dosage forms of acid labile drug
|
EP1833469A2
(de)
*
|
2005-01-03 |
2007-09-19 |
Lupin Ltd. |
Pharmazeutische zusammensetzung aus säurelabilen substanzen
|
EP1855690B1
(de)
*
|
2005-01-21 |
2016-06-01 |
Warner Chilcott Company, LLC |
Tetracyclin-metall-komplex in einer festen dosierform
|
US20060280843A1
(en)
*
|
2005-02-23 |
2006-12-14 |
Ralf Jager |
Filler for a beverage container
|
WO2006090845A1
(ja)
|
2005-02-25 |
2006-08-31 |
Takeda Pharmaceutical Company Limited |
顆粒の製造方法
|
US20060210637A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Qpharma, Llc |
Stable tablet dosage forms of proton pump inhibitors
|
US20070015782A1
(en)
|
2005-04-15 |
2007-01-18 |
Eisai Co., Ltd. |
Benzimidazole compound
|
PT1878426E
(pt)
*
|
2005-04-26 |
2010-06-28 |
Dainippon Sumitomo Pharma Co |
Preparação granulada contendo um composto de biguanida
|
WO2006118017A1
(ja)
*
|
2005-04-28 |
2006-11-09 |
Eisai R & D Management Co., Ltd. |
安定化組成物
|
US9040564B2
(en)
|
2005-04-28 |
2015-05-26 |
Eisai R&D Management Co., Ltd. |
Stabilized composition
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
US20070026071A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Qpharma, Llc |
Magnesium salt proton pump inhibitor dosage forms
|
JP2009511481A
(ja)
*
|
2005-10-06 |
2009-03-19 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
増強された治療特性を持つ、胃H+,K+−ATPaseの重水素化阻害剤
|
JP5160423B2
(ja)
|
2006-07-19 |
2013-03-13 |
旭化成ケミカルズ株式会社 |
水易溶性薬物含有球状素顆粒の製造方法
|
AU2007275034A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophilic abuse deterrent delivery system
|
JP5271081B2
(ja)
*
|
2006-07-26 |
2013-08-21 |
旭化成ケミカルズ株式会社 |
球形素顆粒およびその製造方法
|
JP5171626B2
(ja)
*
|
2006-08-11 |
2013-03-27 |
旭化成ケミカルズ株式会社 |
水難溶性薬物含有球形素顆粒の製造方法
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
GB2444593B
(en)
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
WO2008081891A1
(ja)
*
|
2006-12-28 |
2008-07-10 |
Takeda Pharmaceutical Company Limited |
口腔内崩壊性固形製剤
|
AU2008213744B2
(en)
*
|
2007-02-09 |
2013-12-05 |
Alphapharm Pty Ltd |
A dosage form containing two or more active pharmaceutical ingredients in different physical forms
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
US8895061B2
(en)
*
|
2007-03-02 |
2014-11-25 |
Meda Pharmaceuticals Inc. |
Compositions comprising carisoprodol and methods of use thereof
|
EP2143424A4
(de)
*
|
2007-03-26 |
2013-07-31 |
Teikoku Seiyaku Kk |
Orale pharmazeutische zubereitung zur spezifischen abgabe an das kolon
|
TW200914006A
(en)
*
|
2007-07-12 |
2009-04-01 |
Takeda Pharmaceutical |
Coated preparation
|
CN102014638A
(zh)
*
|
2007-10-12 |
2011-04-13 |
武田制药北美公司 |
与食物摄入无关的治疗胃肠病症的方法
|
CA2716367C
(en)
|
2008-02-20 |
2015-05-26 |
The Curators Of The University Of Missouri |
Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
|
CA2736547C
(en)
*
|
2008-09-09 |
2016-11-01 |
Pozen Inc. |
Method for delivering a pharmaceutical composition to patient in need thereof
|
US8900634B2
(en)
|
2008-11-03 |
2014-12-02 |
Nal Pharmaceuticals, Ltd. |
Diethylstilbestrol dosage form and methods of treatment using thereof
|
EA019572B1
(ru)
|
2008-11-18 |
2014-04-30 |
Юсб Фарма, С.А. |
Фармацевтические пероральные композиции с пролонгированным высвобождением, включающие производные 2-оксо-1-пирролидина
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
EA021112B1
(ru)
*
|
2009-06-25 |
2015-04-30 |
Поузен Инк. |
Способ лечения боли и/или воспаления у пациента, нуждающегося в аспириновой терапии
|
MX2011013467A
(es)
|
2009-06-25 |
2012-02-13 |
Astrazeneca Ab |
Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
|
IT1395143B1
(it)
*
|
2009-08-06 |
2012-09-05 |
Sofar Spa |
Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.
|
TWI471146B
(zh)
|
2009-12-02 |
2015-02-01 |
Aptalis Pharma Ltd |
菲索特芬那定(fexofenadine)微膠囊及包含其之組合物
|
CA2782368A1
(en)
|
2009-12-30 |
2011-07-07 |
Avon Products, Inc. |
Cosmetic powder bead compositions
|
US20110212171A1
(en)
*
|
2010-01-08 |
2011-09-01 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
US9795568B2
(en)
|
2010-05-05 |
2017-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Low concentration meloxicam tablets
|
CN103096880B
(zh)
*
|
2010-09-13 |
2016-08-24 |
大鹏药品工业株式会社 |
不愉快味道被掩蔽的含药膜包覆的颗粒
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
EP2535045A1
(de)
|
2011-06-15 |
2012-12-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Pharmazeutische Zusammensetzung von Lansoprazol
|
US9119793B1
(en)
|
2011-06-28 |
2015-09-01 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for doxycycline
|
WO2013101897A2
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
DE102012007671A1
(de)
|
2012-04-16 |
2013-10-17 |
Acino Pharma Ag |
Pellets mit hohem Wirkstoffgehalt
|
EP2890370B1
(de)
|
2012-08-31 |
2019-10-09 |
The Regents of the University of California |
Mittel zur behandlung von adipositas, diabetes und verwandten erkrankungen
|
US10842802B2
(en)
|
2013-03-15 |
2020-11-24 |
Medicis Pharmaceutical Corporation |
Controlled release pharmaceutical dosage forms
|
CN105193757A
(zh)
*
|
2014-06-23 |
2015-12-30 |
中国人民解放军军事医学科学院毒物药物研究所 |
美托洛尔缓释组合物及其制备方法
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
CA3018328A1
(en)
|
2014-10-31 |
2016-04-30 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
GB201420300D0
(en)
|
2014-11-14 |
2014-12-31 |
Bio Images Drug Delivery Ltd |
Tablet
|
GB201420306D0
(en)
|
2014-11-14 |
2014-12-31 |
Bio Images Drug Delivery Ltd |
Compositions
|
GB201420311D0
(en)
|
2014-11-14 |
2014-12-31 |
Bio Images Drug Delivery Ltd |
Pharmaceutical processing
|
AU2015389109B2
(en)
|
2015-03-31 |
2021-04-01 |
Eastbrand Holding Gmbh |
Enteric-coated pellets containing a proton pump inhibitor
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
EP3292862A1
(de)
|
2016-09-07 |
2018-03-14 |
Sandoz Ag |
Omeprazolformulierungen
|
WO2018098501A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
WO2018218211A1
(en)
|
2017-05-26 |
2018-11-29 |
Animal Microbiome Analytics, Inc. |
Products and methods for therapeutic administration of microorganisms to non-human animals
|
CZ2017315A3
(cs)
|
2017-06-02 |
2018-12-12 |
Zentiva, K.S. |
Dávkovací jednotka s PPI (inhibitory protonové pumpy)
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2022178214A1
(en)
|
2021-02-19 |
2022-08-25 |
Dupont Nutrition Biosciences Aps |
Compositions for gut health
|
WO2024040043A1
(en)
|
2022-08-16 |
2024-02-22 |
International N&H Denmark Aps |
Expression systems for phosphatases
|
WO2024064653A1
(en)
|
2022-09-20 |
2024-03-28 |
Dupont Nutrition Biosciences Aps |
Variant anti-viral polypeptides
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|